Old Web
English
Sign In
Acemap
>
authorDetail
>
Ryuji Yoshida
Ryuji Yoshida
Amgen
Clinical endpoint
Migraine
Medicine
Internal medicine
Placebo
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.
2021
Headache
Takao Takeshima
Fumihiko Sakai
Koichi Hirata
Noboru Imai
Yasuhiko Matsumori
Ryuji Yoshida
Cheng Peng
Sunfa Cheng
Daniel D. Mikol
Show All
Source
Cite
Save
Citations (2)
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
2021
Journal of Headache and Pain
Koichi Hirata
Fumihiko Sakai
Takao Takeshima
Noboru Imai
Yasuhiko Matsumori
Ryuji Yoshida
Yotaro Numachi
Cheng Peng
Daniel D. Mikol
Sunfa Cheng
Show All
Source
Cite
Save
Citations (0)
1